Rieger, Kathrin http://orcid.org/0000-0002-2754-8581
De Filippi, Rosaria
Lindén, Ola
Viardot, Andreas
Hess, Georg
Lerch, Kristina
Neumeister, Peter
Stroux, Andrea
Peuker, Caroline A.
Pezzutto, Antonio
Pinto, Antonello
Keller, Ulrich
Scholz, Christian W.
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 2 November 2021
Accepted: 27 January 2022
First Online: 12 February 2022
Declarations
:
: This study (NCT00772655) was performed in line with the principles of the Declaration of Helsinki. Institutional review board approval from each center and informed consent from each patient were obtained.
: K.R. has received honoraria from Roche, BMS, Amgen, Novartis, Janssen-Cilag, and Abbvie, and reports consultant/advisory roles for MSD and Essex Pharma. A.V. has received honoraria from Roche, Amgen, Kite/Gilead, Novartis, and BMS, and reports consultant/advisory roles for Roche, Amgen, Kite/Gilead, Novartis, and BMS. C.A.P. has received honoraria from BMS, Novartis, Daiichi-Sankyo, EUSA Pharma, and Sirtex Medical, and reports a consultant/advisory role for EUSA Pharma. U.K. reports consultant/advisory roles for Roche, BMS, Celgene, Novartis, Gilead, Pentixapharm, EUSA Pharma, Janssen-Cilag, AstraZeneca, Hexal, MSD, Takeda, and Amgen. C.W.S. has received honoraria from GILEAD, Janssen, Pfizer, and Roche, and reports consultant/advisory roles for BMS, Celgene, Daiichi-Sankyo, GILEAD, Hexal, Janssen, Merck Serono, Novartis, Roche, and Takeda. The other authors have no competing interests to declare that are relevant to the content of this article.
: Clinical data contains potentially personal information and is stored with the authors. Upon request, it can be shared in anonymized form with the editors or fellow scientists.